Recent News

The Cancer Fluid Biopsy Research Group
The Cancer Fluid Biopsy Research GroupMonday, February 1st, 2016 at 11:38am
“CTC-based diagnostics are ready for prime time,” Murali Prahalad, CEO of Epic Sciences said. “We’re carrying out molecular analyses, with clonal resolution and assessment of protein, FISH and NGS, gaining insights that were not possible before from malignant cells in blood samples.”

“We look at the individual cells from patients’ blood in real time, and interrogate specific pathway points. This way, we can rationally assign cancer drugs.”

Epic Sciences no cell left behind™ technology is a powerful rare-cell detection and characterization platform, which was founded on unique technology from Dr. Peter Kuhn's lab.
11    View on Facebook
The Cancer Fluid Biopsy Research Group
The Cancer Fluid Biopsy Research GroupTuesday, January 12th, 2016 at 6:20am
Congratulations to our melanoma team! The work entitled “Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients” by Carmen Ruiz et al. was included in a selection of papers published by Physical Biology representing the breadth and excellence of current research on the physics of cancer.

Read the full article at http://iopscience.iop.org/article/10.1088/1478-3975/12/1/016008.
11 1    View on Facebook
The Cancer Fluid Biopsy Research Group
The Cancer Fluid Biopsy Research Group added a new photo.Tuesday, December 29th, 2015 at 7:27pm
8    View on Facebook
The Cancer Fluid Biopsy Research Group
The Cancer Fluid Biopsy Research Group added 27 new photos to the album: Family Holiday Mixer — at USC Bridge Institute.Thursday, December 3rd, 2015 at 9:00am
   View on Facebook
The Cancer Fluid Biopsy Research Group
The Cancer Fluid Biopsy Research GroupWednesday, November 25th, 2015 at 10:23am
WHO WE ARE
Watch video at http://dornsife.usc.edu/videos/featured/1032/the-bridgeusc/

The Bridge@USC is an initiative that unites the best minds in disciplines across the university to build the first atomic resolution structure of man.
2    View on Facebook